News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Daily News SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry Yael L. Maxwell October 20, 2023
News Conference News EACTS 2023 AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair Michael O'Riordan October 09, 2023
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Daily News US and European Valvular Guidelines Mostly Concordant, Analysis Finds L.A. McKeown August 21, 2023
News Daily News Abbott to Stop Making Trifecta Surgical Aortic Valves Michael O'Riordan July 31, 2023
News Daily News TAVI Explantation Remains a Risky Proposition, Two New Studies Show Michael O'Riordan April 27, 2023
News Conference News ACC 2023 Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients Todd Neale March 05, 2023
News Daily News FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves Todd Neale February 27, 2023
News Daily News Adopting TEER Doesn’t Put a Dent in Surgical MV Repair Volumes Todd Neale February 07, 2023
News Daily News Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis Todd Neale January 20, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023